Relocation reflects Orchestra’s commitment to innovation, ecosystem growth, and building the advanced
therapy workforce of the future
Philadelphia, PA, October 22, 2025 — Orchestra Life Sciences (OLS), a premier technical consultancy
firm specializing in advanced therapy manufacturing solutions, today announced the relocation of its
global headquarters from Montreal, Quebec, to Philadelphia, Pennsylvania. The new headquarters at
the Navy Yard positions Orchestra at the center of one of the nation’s most dynamic life sciences hubs
and marks a major step in the company’s expansion.
Led by Co-Founder and CEO Emilie Pelletier, Orchestra has experienced rapid growth over the past three
years, expanding from a four-person team to more than 60 employees and consultants worldwide.
Collectively, the team brings over 500 years of expertise in nuclear medicine and 100 years in cell and
gene therapy, enabling clients to move therapies from concept to commercialization with confidence.
“Relocating our headquarters to Philadelphia reflects both our growth as a company and our
commitment to being part of this extraordinary ecosystem,” said Emilie Pelletier, CEO of Orchestra Life
Sciences. “The Navy Yard provides not only world-class infrastructure, but also the community and
vision to build the workforce needed for the future of advanced therapies. We’re proud to contribute to
that momentum as we help our partners deliver life-saving treatments to patients.”
As part of the relocation, Orchestra will be co-located with its future workforce development program at
the Navy Yard. The initiative, slated for launch in 2026, will provide specialized hands-on training
programs for operations, quality control, and quality assurance roles in high-demand fields of cell and
gene therapy and radiopharmaceutical manufacturing. By creating a dedicated environment for
workforce readiness, Orchestra aims to address the nationwide shortage of an estimated 400–600
production operators and 400–800 QA/QC technicians and prepare the next generation of technical
leaders.
“Businesses like Orchestra Life Sciences are choosing the Philadelphia region again and again because of
our diverse and highly skilled talent pool, world class transportation and infrastructure assets, and
growing innovation economy,” said Claire Marrazzo Greenwood of the Chamber of Commerce for
Greater Philadelphia. “Not only does their decision validate our region’s strength in advanced
therapeutics, but it will continue to fuel innovation and manufacturing across the region that supports
thousands of life sciences jobs and billions in private investments.”
“Having Orchestra join us at the Navy Yard is a major win for the life sciences community,” said Mark
Seltzer, Managing Director at Ensemble Investments. “With their workforce initiative launching here,
Orchestra will complement and strengthen the ongoing workforce development initiatives already
thriving at the Navy Yard, ensuring the region has the skilled talent to sustain its growth for years to
come.”
About Orchestra Life Sciences
Orchestra Life Sciences (OLS) is a technical consultancy providing strategic support and scientific
expertise to advance pharmaceutical therapies for cancer and rare diseases. The company specializes in
engineering solutions, operational excellence, and quality compliance services for advanced therapy
manufacturing facilities. Their comprehensive approach encompasses facility design, process
optimization, and implementation of cutting-edge manufacturing technologies. With a focus on
innovation and efficiency, OLS helps clients navigate complex technical challenges while maintaining the
highest standards of quality and regulatory compliance.
About PIDC and the Philadelphia Navy Yard
PIDC is Philadelphia’s public-private economic development corporation. Since acquiring the 1,200-acre
site from the federal government in 2000, PIDC has been the master developer and site operator of the
Navy Yard. PIDC’s mission—to spur investment, support business growth, and facilitate developments
that create jobs, revitalize neighborhoods, and drive growth to every corner of Philadelphia—strongly
informs its strategy for the Navy Yard, where the focus is on building a cohesive community that fosters
employment, innovation, and production. PIDC manages all aspects of the property’s management and
development, including master planning, leasing, property management, infrastructure development,
utility operation, and structuring development transactions. For more information, please visit
www.pidcphila.com|www.navyyard.org.
For more information about Orchestra, please contact:
Alexis Taylor
Orchestra Marketing & PR
alexis@tayloredmarketinggroup.com
For information about the Navy Yard, please contact:
Tracy Buchholz
Director of Public Relations
tracy@enroutemarketing.com